Home arrow Supplements arrow Flax Lignans arrow Lignans and cardiovascular health
Lignans and cardiovascular health PDF Print E-mail

According to the Center for Disease Control:
    Heart disease and stroke—the principal components of cardiovascular disease—are the first and third leading causes of death in the United States, accounting for 40 percent of the deaths in the U.S.

    Although heart disease and stroke are often thought to affect men and older people primarily, it is also a major killer of women and people in the prime of life.

    About 16 million Americans (almost one fourth of the population) have some form of cardiovascular disease.

    Coronary heart disease is a leading cause of premature permanent disability among working adults.

    Almost six million hospitalizations each year are due to cardiovascular disease.

    The overall cost of heart disease and stroke in 2003 is estimated to be $351 billion.
With these staggering statistics, it is no wonder that people are interested in natural products that may promote heart health. Cardiovascular disease is the result of atherosclerosis, in which deposits of cholesterol and other substances accumulate and form plaque on artery walls. Plaque build-up can gradually narrow the inside of the artery, restricting blood flow. Sometimes plaque breaks away from the artery wall, which can cause a blood clot. A heart attack or stroke can occur when blood flow is completely blocked. High cholesterol is a risk factor for cardiovascular disease. Free radicals are also implicated in the development of atherosclerosis or hardening of the artery walls.

Today Americans are turning to more natural ingredients to maintain overall heart health and reduce risk factors to the heart. Studies suggest that the dietary fiber and certain fatty acids in flax can help reduce risks of cardiovascular disease. Research also suggests that flax lignans play a role in cardiovascular health. Secoisolariciresinol diglycoside (SDG) is a plant lignan isolated from flaxseed. In addition to being a phytoestrogen, SDG is a strong antioxidant (which is associated with a reduced risk of atherosclerosis).

The antioxidant SDG is also metabolized to secoisolariciresinol (SECO), enterodiol (ED) and enterolactone (EL) in the body. The effectiveness of SDG in heart health could be due to these metabolites and their powerful antioxidant activity. Testing has shown these metabolites individually to deliver three times more antioxidant potency than their precursor SDG and up to five times more potency than vitamin E.

Studies in humans have found that flaxseed taken daily can reduce total and bad (LDL) cholesterol levels, because whole flaxseed contains several heart health components (fatty acids, fiber and lignans) these studies could not tell us how much effect is due to the lignans. Recently a study was done in rabbits, using lignans (SDG) isolated from flaxseed. The object of the study was to determine the effect of the lignans on cholesterol, oxidative stress and on the development of atherosclerosis in rabbits fed a high cholesterol diet.

Results showed that the flax lignan SDG reduced deposits of cholesterol, plaque build-up and other substances on the artery walls (atherosclerosis) by as much as 73 percent. The reduction of atherosclerosis was associated with a reduction in oxidative stress. The lignans also reduced total and bad (LDL) cholesterol. These results suggest that the heart benefits of SDG may be due to its antioxidant activity and a lipid lowering effect.


Studies suggest that the dietary fiber and certain fatty acids in flax can help reduce risks of cardiovascular disease. Research also suggests that flax lignans play a role in cardiovascular health.
 
< Prev   Next >
© 2008 www.americanwellnessnetwork.com